Catalyst Pharmaceuticals (CPRX) Shares Outstanding (2010 - 2026)

Catalyst Pharmaceuticals (CPRX) has 17 years of Shares Outstanding (Entity) data on file, last reported at $122.2 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.18% year-over-year to $122.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.2 million (changed 0.18% YoY) and the FY2025 annual result came in at $122.5 million, up 1.35% from the prior year.
• Shares Outstanding (Entity) held at $122.2 million in Q1 2026, from $122.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $123.3 million in Q3 2025 to a low of $102.7 million in Q2 2022.
• A 5-year average of $113.5 million and a median of $118.0 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) slipped 0.82% — and 2024, when it advanced 12.84%.
• Tracing CPRX's Shares Outstanding (Entity) over 5 years: stood at $105.3 million in 2022, then rose by 1.77% to $107.1 million in 2023, then increased by 12.84% to $120.9 million in 2024, then rose by 1.35% to $122.5 million in 2025, then slipped by 0.27% to $122.2 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $122.2 million (Q1 2026), $122.5 million (Q4 2025), and $123.3 million (Q3 2025), per Business Quant data.